DiscoverInside Forbes IndiaSun Pharma's Quiet Architect: Inside Dilip Shanghvi's vision
Sun Pharma's Quiet Architect: Inside Dilip Shanghvi's vision

Sun Pharma's Quiet Architect: Inside Dilip Shanghvi's vision

Update: 2025-04-30
Share

Description

In the latest episode of Inside Forbes India Podcast, Naini Thaker discusses her deep-dive profile on Dilip Shanghvi, the low-key founder of Sun Pharma, India's largest pharmaceutical company. Starting with just $200, Shanghvi's strategic focus on chronic therapies and high-value acquisitions—most notably Ranbaxy—helped shape Sun Pharma into a global force. The conversation explores how the company weathered challenges, such as price erosion, by doubling down on R&D and pivoting toward complex speciality drugs. It also highlights that Shanghvi's leadership is marked by humility, passion for his work, and a focus on patient care rather than wealth accumulation.

Comments 
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Sun Pharma's Quiet Architect: Inside Dilip Shanghvi's vision

Sun Pharma's Quiet Architect: Inside Dilip Shanghvi's vision

Forbes India